20% Off | Aarkstore.com || Hereditary angioedema (hae) – pipeline review, h2 2012

1. You can also request for sample page of above
mention reports on sample@aarkstore.com

2. Pages : 82
PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $
6000 |
20% Off on above 1000$ Reports
25% off on purchase of 2 reports and 30% on purchase of
3 or more reports.
Discount till 31st Dec. 2012.

3. Summary
Global Markets Direct’s, Hereditary Angioedema (HAE) - Pipeline Review,
H2 2012, provides an overview of the indication’s therapeutic pipeline. This
report provides information on the therapeutic development for Hereditary
Angioedema (HAE), complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players involved in
the therapeutic development for Hereditary Angioedema (HAE). Hereditary
Angioedema (HAE) - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific
third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.

4. Scope
- A snapshot of the global therapeutic scenario for Hereditary Angioedema
(HAE).
- A review of the Hereditary Angioedema (HAE) products under development by
companies and universities/research institutes based on information derived
from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Hereditary Angioedema (HAE).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.

5. Table of Contents :
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Hereditary Angioedema (HAE) Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Hereditary Angioedema (HAE) 8
Hereditary Angioedema (HAE) Therapeutics under Development by
Companies 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Pre-Clinical Stage Products 14
Comparative Analysis 14
Hereditary Angioedema (HAE) Therapeutics – Products under
Development by Companies 15……………….

6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline
Review, H2 2012&PubId=&pagenum=1

7. Related Reports:
Generalized Seizures – Pipeline Review, H2 2012
Cataract – Pipeline Review, H2 2012
Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2
2012
Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012
Erosive Oral Lichen Planus – Pipeline Review, H2 2012
Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012
Blepharitis – Pipeline Review, H2 2012
Hypoparathyroidism – Pipeline Review, H2 2012
Lyme Disease – Pipeline Review, H2 2012
Optic Nerve Injury – Pipeline Review, H2 2012
Auto Inflammatory Disease – Pipeline Review, H2 2012

8. For More details about above & other
Reports plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team Mob.No.918149852585
Email: enquiry@aarkstore.com ,
discount@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore